Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrol

por Zajkowicz, Artur, Krześniak, Małgorzata, Matuszczyk, Iwona, Głowala-Kosińska, Magdalena, Butkiewicz, Dorota, Rusin, Marek
Publicado 2013

Synergistic activation of p53 by actinomycin D and nutlin-3a is associated with the upregulation of crucial regulators and effectors of innate immunity

por Krześniak, Małgorzata, Zajkowicz, Artur, Gdowicz-Kłosok, Agnieszka, Głowala-Kosińska, Magdalena, Łasut-Szyszka, Barbara, Rusin, Marek
Publicado 2020

Transcriptome Analysis of Cells Exposed to Actinomycin D and Nutlin-3a Reveals New Candidate p53-Target Genes and Indicates That CHIR-98014 Is an Important Inhibitor of p53 Activit...

por Łasut-Szyszka, Barbara, Małachowska, Beata, Gdowicz-Kłosok, Agnieszka, Krześniak, Małgorzata, Głowala-Kosińska, Magdalena, Zajkowicz, Artur, Rusin, Marek
Publicado 2021